Same Indication

Hydromorphone vs Nivolumab

Hydromorphone vs Nivolumab: Overview

This comparison examines the pharmacological differences between Hydromorphone and Nivolumab.

Mechanism of Action

Hydromorphone: Semisynthetic mu-opioid receptor agonist approximately 5 times more potent than morphine.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Hydromorphone — 2-3 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Hydromorphone — C17H19NO3.

Molecular Weight: Hydromorphone — 285.3380 g/mol.

Type: Hydromorphone — Small molecule; Nivolumab — Antibody.